Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 73
- Cultivation
High-THC cannabis cultivation licences now available in Guernsey
The long-awaited MoU will ensure that the Bailiwick is at the forefront of the developing cannabis sector
- Adult-Use
Akanda CEO discusses ESG and disruption in European cannabis market
Tej Virk is appointed as CEO of Akanda as Halo Collective reorganises its international assets into the newly formed company
- Companies
AssetCo acquires 63% stake in Rize ETF for £16.5m
The 63% acquisition will see a further investment of £5.25m to help fund the growth of the business
- Medical
Knowde Group and LMC Manna partner to drive cannabis research
The partnership will help to accelerate and advance research for both cannabis and psychedelics.
- CBD Market
Claudia Winkleman announced as Cannaray CBD brand ambassador
The announcement marks the launch of Cannaray’s “Join the CBD Revolution” national outdoor and digital advertising campaign.
- Companies
New CFO Ranjan Kalia appointed to Curaleaf
Kalia joined international provider of cannabis products Curaleaf Holdings, Inc. as CFO on 19 July.
- CBD Market
Canxchange benchmark report reveals outlook of European hemp market
The Canxchange Farmers Sentiment Index (CFSI) shows a fairly optimistic outlook from European hemp farmers.
- Medical
Apollon Formularies cannabis products effective at killing prostate cancer
The Apollon medical cannabis formulations are an opportunity for more men to have their prostate cancer treated.
- CBD Market
MGC Pharma cannabinoid drug delivery system patent accepted
MGC Pharma anticipates that the patent for its novel SNEDDS formulation will be issued within the coming 12 months.
- Policy & Regulation
Deregulating cannabis gives UK opportunity after Covid-19
Lawyer from London law firm Bishop & Sewell, Eleanor Furlong, says the deregulation of cannabis in the UK is a case of ‘when, not if’.
- Companies
CanCoin to accelerate European cannabis industry with blockchain
CanCoin, a new token that utilises blockchain technology, has been launched to accelerate the European cannabis industry.
- Companies
Kanabo launches cannabis extract formula for metered dosing
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief in a metered dose.
